American Bio Medica Co. (OTCMKTS:ABMC – Get Rating)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.03 and traded as low as $0.02. American Bio Medica shares last traded at $0.02, with a volume of 14,800 shares changing hands.
The company has a 50 day simple moving average of $0.02 and a 200 day simple moving average of $0.03.
American Bio Medica (OTCMKTS:ABMC – Get Rating) last released its quarterly earnings results on Monday, May 16th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.35 million during the quarter.
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs.
- Get a free copy of the StockNews.com research report on American Bio Medica (ABMC)
- The Analysts Upgrade… Retail Stocks?
- Dividend Stocks and Your Roth IRA
- The Q2 Earnings Season Could Be A Bloodbath
- Commercial Metals Company Is Ready To Rebound
- The Institutions Turn The Tide For Jabil
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for American Bio Medica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Bio Medica and related companies with MarketBeat.com's FREE daily email newsletter.